|
|
| RAC December 6, 2002 - Presentation Materials |
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
Discussion of Human Gene Transfer Protocol #0208-550 entitled |
|
|
| |
A Phase I/II Study of an Antitumor Vaccination Using (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Relapsed or Refractory Breast Cancer |
|
|
| |
Roscoe F. Morton, M.D., Stoddard Cancer Research Institute, Iowa Methodist Medical Center |
|
|
| |
Slides
|
|
| |
|
|
|
ADJOURN |
|
| |
|
Top of Page |
| |
|
|
|
|
